Nutrition 21 Appoints Pam McWilliams, Vice President - General Manager of Direct Response
Published In: Business, New York 
Thursday, October 30, 2008 7:30 AM
< Archive for Mar 2010 >
SuMoTuWeThFrSa
 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
PURCHASE, N.Y., Oct. 30 /PRNewswire-FirstCall/ -- Nutrition 21, Inc.,
(Nasdaq: NXXI) today announced the appointment of Pam McWilliams as vice
president and general manager of the Company's Direct Response Group,
effective October 27, 2008. Mrs. McWilliams has more than 22 years of
experience in sales, marketing, management and business development within the
direct response industry. Mrs. McWilliams' responsibilities include new
business development, sales strategy, vendor operations and management of the
Direct Response Group.

Mrs. McWilliams will be based out of Nutrition 21's headquarters in
Purchase, NY and will report to Michael A. Zeher, president and CEO of
Nutrition 21, who said, "I am very pleased that Pam McWilliams is joining the
Nutrition 21 management team. Her excellent experience, broad background, and
relationships in the direct response industry will be valuable assets to our
company. I am looking forward to the combination of Pam's leadership skills,
high integrity, and business acumen being an energizing force in leading
Nutrition's 21's Direct Response Group to even higher levels of performance."

"I am extremely pleased to join the leadership team at Nutrition 21," said
Mrs. McWilliams. The value the company places on integrity, industry
leadership, and supporting high quality brands in the bioscience industry is
what attracted me to Nutrition 21. These values create an exciting opportunity
to differentiate Nutrition 21 from its competitors, increase market share, and
achieve unprecedented levels of customer satisfaction and long term brand
loyalty. By drawing from my professional experience and collaborating with the
leadership team, Nutrition 21 will continue to implement a direct marketing
strategy to deliver cutting edge, high quality nutritional supplements with a
demonstrated commitment towards best-in-class customer service."

For the past two years Mrs. McWilliams was a direct marketing consultant
for Propeller Consulting. Prior to that Mrs. McWilliams served for 21 years at
Bee Alive, Inc., a direct marketing health and beauty company, most recently
as executive vice president. Beginning as a three-person operation, Mrs.
McWilliams helped grow the Bee Alive organization to 150 employees while
achieving millions in annual sales. Mrs. McWilliams' responsibilities included
management and business development, return on investment (ROI) analysis,
marketing and promotion, product development, profit and loss (P&L), expense
management, and systems implementation.


About Nutrition 21

Nutrition 21, Inc. (NASDAQ: NXXI), headquartered in Purchase, NY, is a
nutritional bioscience company and the maker of chromium picolinate-based and
omega-3 fish oil-based supplements with health benefits substantiated by
clinical research. Nutrition 21 holds more than 30 patents for nutrition
products and uses. Nutrition 21's portfolio of health and wellness products
include: Iceland Health Chromax(R), Iceland Health Advanced Memory
Formula(TM), Diabetes Essentials(R), Iceland Health(R) Maximum Strength
Omega-3 and Iceland Health(R) Joint Relief. The company also manufactures
private label supplements and ingredients for third parties. Nutrition 21
distributes its products nationally through more than 29,000 major food, drug
and super center stores throughout the United States and internationally. For
more information please visit http://www.nutrition21.com.


Safe Harbor Provision

This press release may contain certain forward-looking statements. The
words "believe," "expect," "anticipate" and other similar expressions
generally identify forward-looking statements. Readers are cautioned not to
place undue reliance on these forward-looking statements, which speak only as
of their dates. These forward-looking statements are based largely on the
Company's current expectations and are subject to a number of risks and
uncertainties, including without limitation: the effect of the expiration of
patents; regulatory issues; uncertainty in the outcomes of clinical trials;
changes in external market factors; changes in the Company's business or
growth strategy or an inability to execute its strategy due to changes in its
industry or the economy generally; the emergence of new or growing
competitors; various other competitive factors; and other risks and
uncertainties indicated from time to time in the Company's filings with the
Securities and Exchange Commission, including its Form 10-K/A for the year
ended June 30, 2008. Actual results could differ materially from the results
referred to in the forward-looking statements. In light of these risks and
uncertainties, there can be no assurance that the results referred to in the
forward-looking statements contained in this press release will in fact occur.
Additionally, the Company makes no commitment to disclose any revisions to
forward-looking statements, or any facts, events or circumstances after the
date hereof that may bear upon forward-looking statements.


Company Contact: Investor Contact:
Alan Kirschbaum Lytham Partners, LLC
Chief Financial Officer Joe Diaz, Joe Dorame, Robert Blum
914-701-4500 602-889-9700


SOURCE Nutrition 21, Inc.


 
Thursday, October 30, 2008 7:30 AM

Share Socially:
BlinkListBlinkList del.icio.usdel.icio.us DiggDigg FurlFurl ma.gnoliama.gnolia redditreddit SimpySimpy SpurlSpurl BlogMarksBlogMarks NewsvineNewsvine Share on Facebook Sphere: Related Content

Related Press Releases

Contact Us | Terms of Use | Trademarks | Privacy Statement
(c) 2008-2009 Press Related